MESOBLAST LIMITED - Announcements

0.87%

$2.31

Market Cap $2.931B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

MSB	Mesoblast Management Presentation		24/08/11	555.31KB	Share
MSB	Mesoblast in Position of Considerable Strength		24/08/11	282.11KB	Share
MSB	Preliminary Final Report	PRICE SENSITIVE	24/08/11	599.08KB	Share
MSB	First Minimally Invasive Procedure for Lumbar Disc Repair	PRICE SENSITIVE	22/08/11	202.43KB	Share
MSB	Heart Failure Trial Selected for AHA Special Session		15/08/11	185.32KB	Share
MSB	Form 604 - Notice of change of interests of substantial hold		01/08/11	67KB	Share
MSB	Appendix 4C - quarterly	PRICE SENSITIVE	01/08/11	177.38KB	Share
MSB	FDA Clearance for Phase 3 Bone Marrow Transplant Trial	PRICE SENSITIVE	07/07/11	230.27KB	Share
MSB	Appendix 3B		06/07/11	184.43KB	Share
MSB	Amended Change of Director's Interest Notice		04/07/11	173.29KB	Share
MSB	Change of Director's Interest Notice		01/07/11	98.49KB	Share
MSB	FDA Clears Phase 2 Trial to Treat Degenerative Disc Disease	PRICE SENSITIVE	29/06/11	144.65KB	Share
MSB	FORM 604 CHANGE OF INTERESTS OF SUB HOLDER		22/06/11	68.7KB	Share
MSB	Key Product Franchises Featured at Nomura Asia Equity Forum	PRICE SENSITIVE	14/06/11	960.14KB	Share
MSB	Revascor Increases Blood Supply to Damaged Heart Muscle	PRICE SENSITIVE	09/06/11	252.13KB	Share
MSB	MSB to Present at Goldman Sachs Global Healthcare Conference		06/06/11	115.31KB	Share
MSB	Key USA Patents Increase Commercial Rights and Indications	PRICE SENSITIVE	24/05/11	145.42KB	Share
MSB	FORM 604 CHANGE OF INTERESTS OF SUB HOLDER		04/05/11	55.04KB	Share
MSB	Appendix 4C - quarterly	PRICE SENSITIVE	02/05/11	128.9KB	Share
MSB	SandP to remove Tower Australia Group from SP/ASX Indices		18/04/11	29.48KB	Share
MSB	Mesoblast Included in S and P/ASX 200 Index	PRICE SENSITIVE	18/04/11	153.75KB	Share
MSB	Appendix 3B		11/04/11	162.66KB	Share
MSB	Mesoblast Update on Valeant Proposal to Cephalon	PRICE SENSITIVE	07/04/11	206.41KB	Share
MSB	Mesoblast Statement on Valeant Proposal to Cephalon		31/03/11	129.72KB	Share
MSB	Mesoblast CEO Named BioSpectrum Asia Person of the Year 2011		17/03/11	204.96KB	Share
MSB	Appendix 3B		11/03/11	164.54KB	Share
MSB	FORM 604 CHANGE OF INTERESTS OF SUB HOLDER		10/03/11	55.01KB	Share
TSN +ADU AGO AIA AIZ AKM ALK ALS ARP ATI AVX AXM AZM AZT AZZ ASQ BDR BND BTU BUL CAA CCC CHN CMG AEL COF COK CPB CQT CRK CSS CTO CUP CVW DML DTE GSL EDT ELD K2P EPW EQN EQX EXS FBU FGE FPA GCL JNS GEM GLG GRY GUF GWR NGI HIG HIN HUN ICN IFM IGR IMD IPD ISF IVA IXR JMS KGD KGL KRM MAQ MCE MCO MEL MGO MLD MMW LCL MSB NBS NCK NCR NFK NGE ACF BLV NPX NYO ECH PBP PEM PEN PLA PLV OVT PPP SRS PVE QRX QTM RCI RES RFE RIA RMS ROL RRS RUL RXM SDG SEA SIH SLM SRV SSN STB SWK SWL SPK TEN TGS TLM PAC TSI TWR TZN UML UXC VPG VTA WDS WHS WIG WPG WRT ZSP	SandP Announces March SP/ASX Rebalance		04/03/11	38.04KB	Share
MSB	Appendix 4D and Half Year Financial Report to 31 Dec 2010	PRICE SENSITIVE	28/02/11	625.04KB	Share
MSB	FORM 604 CHANGE OF INTERESTS OF SUB HOLDER		17/02/11	54.26KB	Share
MSB	Change in substantial holding		15/02/11	125.7KB	Share
MSB	Cleansing Notice under Section 708A		14/02/11	132.75KB	Share
MSB	Mesoblast Issues New Equity to Cephalon, Increases Cash		14/02/11	146.91KB	Share
MSB	Section 708AA Notice - Cleansing Statement		11/02/11	98.23KB	Share
MSB	Appendix 3B		11/02/11	166.6KB	Share
MSB	Results of Meeting		09/02/11	137.1KB	Share
MSB	Mesoblast EGM Speech and Presentation		09/02/11	775.19KB	Share
MSB	Appendix 4C - Strong Cash Position	PRICE SENSITIVE	31/01/11	353.14KB	Share
MSB	Response to ASX Price Query	PRICE SENSITIVE	13/01/11	193.53KB	Share
MSB	FORM 604 CHANGE OF INTERESTS OF SUB HOLDER		13/01/11	54.12KB	Share
MSB	Alliance Highlighted at JP Morgan Healthcare Conference		12/01/11	1.32MB	Share
MSB	Cardiac Events, Mortality and Hospitalization Reduced	PRICE SENSITIVE	10/01/11	160.49KB	Share
MSB	Notice of Extraordinary General Meeting/Proxy Form		07/01/11	528.58KB	Share
MSB	Initial Director's Interest Notice		31/12/10	84.17KB	Share
MSB	Change of Director's Interest Notice		30/12/10	12.94KB	Share
MSB	Mesoblast Share Trading Policy Updated		30/12/10	52.84KB	Share
MSB	Change in substantial holding		29/12/10	54.29KB	Share
MSB	Change in substantial holding		24/12/10	38.11KB	Share
MSB	Change of Director's Interest Notice		24/12/10	99.48KB	Share
MSB	Change in substantial holding		24/12/10	256.64KB	Share
MSB	FORM 603 INITIAL SUB FOLDER		24/12/10	30.69KB	Share
MSB	Section 708AA Notice - Cleansing Statement		23/12/10	98.64KB	Share
MSB	Becoming a substantial holder		23/12/10	114.94KB	Share
MSB	Appendix 3B		23/12/10	206.23KB	Share
MSB	Mesoblast Completes Acquisition of Angioblast	PRICE SENSITIVE	23/12/10	139.66KB	Share
MSB	Mesoblast And Cephalon Enter Into Strategic Alliance	PRICE SENSITIVE	08/12/10	200.21KB	Share
MSB	Trading Halt	PRICE SENSITIVE	06/12/10	263.55KB	Share
MSB	Final Director's Interest Notice		01/12/10	91.7KB	Share
MSB	Results of Meeting		29/11/10	135.77KB	Share
MSB	Director Appointment/Resignation		29/11/10	76.67KB	Share
MSB	Chairman's Address and CEO Presentation to AGM		29/11/10	606.09KB	Share
MSB	Mesoblast Clear To Proceed With Angioblast Acquisition	PRICE SENSITIVE	19/11/10	99.23KB	Share
MSB	Novel Heart Attack Treatment Results Presented to US Forum	PRICE SENSITIVE	16/11/10	140.28KB	Share
MSB	US Govt Grants for Further Development of Stem Cell Products	PRICE SENSITIVE	08/11/10	123.67KB	Share
MSB	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	222.14KB	Share
MSB	Annual Report to shareholders		29/10/10	859.22KB	Share
MSB	Notice of Annual General Meeting/Proxy Form		29/10/10	637.55KB	Share
MSB	Positive Results From Phase 2 Lumbar Fusion Trial	PRICE SENSITIVE	21/10/10	123.53KB	Share
MSB	Angioblast Stockholders Approve Acquisition By Mesoblast	PRICE SENSITIVE	20/10/10	119.61KB	Share
MSB	Mesoblast Targets Broader Cancer Indications	PRICE SENSITIVE	14/10/10	139.03KB	Share
MSB	Appendix 3B		06/10/10	165.14KB	Share
MSB	Results of EGM		22/09/10	136.76KB	Share
MSB	Acquisition of US Company Ratified by Mesoblast Shareholders		22/09/10	133.06KB	Share
MSB	Chairman and CEO Presentations to EGM		22/09/10	1.69MB	Share
MSB	Mesoblast Featured at International Scientific Conferences		20/09/10	121.62KB	Share
MSB	Appendix 3B		13/09/10	162.66KB	Share
MSB	Response to an ASX Price Query	PRICE SENSITIVE	10/09/10	153.86KB	Share
MSB	Independent Expert's Report August 2010		27/08/10	1.76MB	Share
MSB	Preliminary Final Report	PRICE SENSITIVE	26/08/10	666.9KB	Share
MSB	Mesoblast Financial Year End Results		26/08/10	144.53KB	Share
MSB	Mesoblast - Notice of Extraordinary General Meeting		23/08/10	2.19MB	Share
MSB	On Track for Phase 3 BMT Trial After Positive FDA Meeting	PRICE SENSITIVE	16/08/10	148.95KB	Share
MSB	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	220.93KB	Share
MSB	TGA Approval To Commercially Manufacture Stem Cell Products	PRICE SENSITIVE	21/07/10	93KB	Share
MSB	Phase 3 Meeting Set With FDA On Bone Marrow Regeneration		12/07/10	67.52KB	Share
MSB	Phase 3 Meeting Set With FDA On Bone Marrow Regeneration	PRICE SENSITIVE	12/07/10	67.55KB	Share
MSB	Appendix 3B		06/07/10	165.16KB	Share
MSB	Appendix 3B		16/06/10	165.46KB	Share
MSB	Mesoblast Featured at Inaugural ASX Singapore Conference		28/05/10	52.18KB	Share
MSB	Ceasing to be a substantial holder		19/05/10	24.51KB	Share
MSB	Appendix 3B		19/05/10	165.31KB	Share
MSB	USA FDA Clears Phase 2 Trial For Cervical Spinal Fusion	PRICE SENSITIVE	19/05/10	52.31KB	Share
MSB	Mesoblast To Acquire Angioblast Systems, 37M Capital Raising	PRICE SENSITIVE	12/05/10	65.33KB	Share
MSB	Reinstatement to Official Quotation	PRICE SENSITIVE	12/05/10	33.32KB	Share
MSB	Suspension from Official Quotation	PRICE SENSITIVE	05/05/10	263.21KB	Share
MSB	Trading Halt	PRICE SENSITIVE	03/05/10	121.33KB	Share
MSB	Appendix 4C and Clinical Trial Update	PRICE SENSITIVE	30/04/10	218.78KB	Share
MSB	Appendix 3B		30/04/10	165.13KB	Share
MSB	Appendix 3B		09/04/10	166.33KB	Share
MSB	Market Exclusivity Strengthened by New USA Healthcare Act	PRICE SENSITIVE	06/04/10	64.34KB	Share

MSBMesoblast Management Presentation
24/08/11		555.31KB	Share
MSBMesoblast in Position of Considerable Strength
24/08/11		282.11KB	Share
MSBPreliminary Final Report
24/08/11	PRICE SENSITIVE	599.08KB	Share
MSBFirst Minimally Invasive Procedure for Lumbar Disc Repair
22/08/11	PRICE SENSITIVE	202.43KB	Share
MSBHeart Failure Trial Selected for AHA Special Session
15/08/11		185.32KB	Share
MSBForm 604 - Notice of change of interests of substantial hold
01/08/11		67KB	Share
MSBAppendix 4C - quarterly
01/08/11	PRICE SENSITIVE	177.38KB	Share
MSBFDA Clearance for Phase 3 Bone Marrow Transplant Trial
07/07/11	PRICE SENSITIVE	230.27KB	Share
MSBAppendix 3B
06/07/11		184.43KB	Share
MSBAmended Change of Director's Interest Notice
04/07/11		173.29KB	Share
MSBChange of Director's Interest Notice
01/07/11		98.49KB	Share
MSBFDA Clears Phase 2 Trial to Treat Degenerative Disc Disease
29/06/11	PRICE SENSITIVE	144.65KB	Share
MSBFORM 604 CHANGE OF INTERESTS OF SUB HOLDER
22/06/11		68.7KB	Share
MSBKey Product Franchises Featured at Nomura Asia Equity Forum
14/06/11	PRICE SENSITIVE	960.14KB	Share
MSBRevascor Increases Blood Supply to Damaged Heart Muscle
09/06/11	PRICE SENSITIVE	252.13KB	Share
MSBMSB to Present at Goldman Sachs Global Healthcare Conference
06/06/11		115.31KB	Share
MSBKey USA Patents Increase Commercial Rights and Indications
24/05/11	PRICE SENSITIVE	145.42KB	Share
MSBFORM 604 CHANGE OF INTERESTS OF SUB HOLDER
04/05/11		55.04KB	Share
MSBAppendix 4C - quarterly
02/05/11	PRICE SENSITIVE	128.9KB	Share
MSBSandP to remove Tower Australia Group from SP/ASX Indices
18/04/11		29.48KB	Share
MSBMesoblast Included in S and P/ASX 200 Index
18/04/11	PRICE SENSITIVE	153.75KB	Share
MSBAppendix 3B
11/04/11		162.66KB	Share
MSBMesoblast Update on Valeant Proposal to Cephalon
07/04/11	PRICE SENSITIVE	206.41KB	Share
MSBMesoblast Statement on Valeant Proposal to Cephalon
31/03/11		129.72KB	Share
MSBMesoblast CEO Named BioSpectrum Asia Person of the Year 2011
17/03/11		204.96KB	Share
MSBAppendix 3B
11/03/11		164.54KB	Share
MSBFORM 604 CHANGE OF INTERESTS OF SUB HOLDER
10/03/11		55.01KB	Share
TSN +ADU AGO AIA AIZ AKM ALK ALS ARP ATI AVX AXM AZM AZT AZZ ASQ BDR BND BTU BUL CAA CCC CHN CMG AEL COF COK CPB CQT CRK CSS CTO CUP CVW DML DTE GSL EDT ELD K2P EPW EQN EQX EXS FBU FGE FPA GCL JNS GEM GLG GRY GUF GWR NGI HIG HIN HUN ICN IFM IGR IMD IPD ISF IVA IXR JMS KGD KGL KRM MAQ MCE MCO MEL MGO MLD MMW LCL MSB NBS NCK NCR NFK NGE ACF BLV NPX NYO ECH PBP PEM PEN PLA PLV OVT PPP SRS PVE QRX QTM RCI RES RFE RIA RMS ROL RRS RUL RXM SDG SEA SIH SLM SRV SSN STB SWK SWL SPK TEN TGS TLM PAC TSI TWR TZN UML UXC VPG VTA WDS WHS WIG WPG WRT ZSPSandP Announces March SP/ASX Rebalance
04/03/11		38.04KB	Share
MSBAppendix 4D and Half Year Financial Report to 31 Dec 2010
28/02/11	PRICE SENSITIVE	625.04KB	Share
MSBFORM 604 CHANGE OF INTERESTS OF SUB HOLDER
17/02/11		54.26KB	Share
MSBChange in substantial holding
15/02/11		125.7KB	Share
MSBCleansing Notice under Section 708A
14/02/11		132.75KB	Share
MSBMesoblast Issues New Equity to Cephalon, Increases Cash
14/02/11		146.91KB	Share
MSBSection 708AA Notice - Cleansing Statement
11/02/11		98.23KB	Share
MSBAppendix 3B
11/02/11		166.6KB	Share
MSBResults of Meeting
09/02/11		137.1KB	Share
MSBMesoblast EGM Speech and Presentation
09/02/11		775.19KB	Share
MSBAppendix 4C - Strong Cash Position
31/01/11	PRICE SENSITIVE	353.14KB	Share
MSBResponse to ASX Price Query
13/01/11	PRICE SENSITIVE	193.53KB	Share
MSBFORM 604 CHANGE OF INTERESTS OF SUB HOLDER
13/01/11		54.12KB	Share
MSBAlliance Highlighted at JP Morgan Healthcare Conference
12/01/11		1.32MB	Share
MSBCardiac Events, Mortality and Hospitalization Reduced
10/01/11	PRICE SENSITIVE	160.49KB	Share
MSBNotice of Extraordinary General Meeting/Proxy Form
07/01/11		528.58KB	Share
MSBInitial Director's Interest Notice
31/12/10		84.17KB	Share
MSBChange of Director's Interest Notice
30/12/10		12.94KB	Share
MSBMesoblast Share Trading Policy Updated
30/12/10		52.84KB	Share
MSBChange in substantial holding
29/12/10		54.29KB	Share
MSBChange in substantial holding
24/12/10		38.11KB	Share
MSBChange of Director's Interest Notice
24/12/10		99.48KB	Share
MSBChange in substantial holding
24/12/10		256.64KB	Share
MSBFORM 603 INITIAL SUB FOLDER
24/12/10		30.69KB	Share
MSBSection 708AA Notice - Cleansing Statement
23/12/10		98.64KB	Share
MSBBecoming a substantial holder
23/12/10		114.94KB	Share
MSBAppendix 3B
23/12/10		206.23KB	Share
MSBMesoblast Completes Acquisition of Angioblast
23/12/10	PRICE SENSITIVE	139.66KB	Share
MSBMesoblast And Cephalon Enter Into Strategic Alliance
08/12/10	PRICE SENSITIVE	200.21KB	Share
MSBTrading Halt
06/12/10	PRICE SENSITIVE	263.55KB	Share
MSBFinal Director's Interest Notice
01/12/10		91.7KB	Share
MSBResults of Meeting
29/11/10		135.77KB	Share
MSBDirector Appointment/Resignation
29/11/10		76.67KB	Share
MSBChairman's Address and CEO Presentation to AGM
29/11/10		606.09KB	Share
MSBMesoblast Clear To Proceed With Angioblast Acquisition
19/11/10	PRICE SENSITIVE	99.23KB	Share
MSBNovel Heart Attack Treatment Results Presented to US Forum
16/11/10	PRICE SENSITIVE	140.28KB	Share
MSBUS Govt Grants for Further Development of Stem Cell Products
08/11/10	PRICE SENSITIVE	123.67KB	Share
MSBAppendix 4C - quarterly
29/10/10	PRICE SENSITIVE	222.14KB	Share
MSBAnnual Report to shareholders
29/10/10		859.22KB	Share
MSBNotice of Annual General Meeting/Proxy Form
29/10/10		637.55KB	Share
MSBPositive Results From Phase 2 Lumbar Fusion Trial
21/10/10	PRICE SENSITIVE	123.53KB	Share
MSBAngioblast Stockholders Approve Acquisition By Mesoblast
20/10/10	PRICE SENSITIVE	119.61KB	Share
MSBMesoblast Targets Broader Cancer Indications
14/10/10	PRICE SENSITIVE	139.03KB	Share
MSBAppendix 3B
06/10/10		165.14KB	Share
MSBResults of EGM
22/09/10		136.76KB	Share
MSBAcquisition of US Company Ratified by Mesoblast Shareholders
22/09/10		133.06KB	Share
MSBChairman and CEO Presentations to EGM
22/09/10		1.69MB	Share
MSBMesoblast Featured at International Scientific Conferences
20/09/10		121.62KB	Share
MSBAppendix 3B
13/09/10		162.66KB	Share
MSBResponse to an ASX Price Query
10/09/10	PRICE SENSITIVE	153.86KB	Share
MSBIndependent Expert's Report August 2010
27/08/10		1.76MB	Share
MSBPreliminary Final Report
26/08/10	PRICE SENSITIVE	666.9KB	Share
MSBMesoblast Financial Year End Results
26/08/10		144.53KB	Share
MSBMesoblast - Notice of Extraordinary General Meeting
23/08/10		2.19MB	Share
MSBOn Track for Phase 3 BMT Trial After Positive FDA Meeting
16/08/10	PRICE SENSITIVE	148.95KB	Share
MSBAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	220.93KB	Share
MSBTGA Approval To Commercially Manufacture Stem Cell Products
21/07/10	PRICE SENSITIVE	93KB	Share
MSBPhase 3 Meeting Set With FDA On Bone Marrow Regeneration
12/07/10		67.52KB	Share
MSBPhase 3 Meeting Set With FDA On Bone Marrow Regeneration
12/07/10	PRICE SENSITIVE	67.55KB	Share
MSBAppendix 3B
06/07/10		165.16KB	Share
MSBAppendix 3B
16/06/10		165.46KB	Share
MSBMesoblast Featured at Inaugural ASX Singapore Conference
28/05/10		52.18KB	Share
MSBCeasing to be a substantial holder
19/05/10		24.51KB	Share
MSBAppendix 3B
19/05/10		165.31KB	Share
MSBUSA FDA Clears Phase 2 Trial For Cervical Spinal Fusion
19/05/10	PRICE SENSITIVE	52.31KB	Share
MSBMesoblast To Acquire Angioblast Systems, 37M Capital Raising
12/05/10	PRICE SENSITIVE	65.33KB	Share
MSBReinstatement to Official Quotation
12/05/10	PRICE SENSITIVE	33.32KB	Share
MSBSuspension from Official Quotation
05/05/10	PRICE SENSITIVE	263.21KB	Share
MSBTrading Halt
03/05/10	PRICE SENSITIVE	121.33KB	Share
MSBAppendix 4C and Clinical Trial Update
30/04/10	PRICE SENSITIVE	218.78KB	Share
MSBAppendix 3B
30/04/10		165.13KB	Share
MSBAppendix 3B
09/04/10		166.33KB	Share
MSBMarket Exclusivity Strengthened by New USA Healthcare Act
06/04/10	PRICE SENSITIVE	64.34KB	Share

REFRESH

First 7 8 9 10 11

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.31		Change 0.020(0.87%)		Mkt cap ! $2.931B

Open	High	Low	Value	Volume
$2.31	$2.33	$2.31	$878.5K	379.1K

Buyers (Bids)

No.	Vol.	Price($)
18	34074	$2.30

Sellers (Offers)

Price($)	Vol.	No.
$2.31	13421	8

View Market Depth

No.	Vol.	Price($)
16	43746	2.300
11	73003	2.290
14	111603	2.280
11	64492	2.270
8	75320	2.260

Price($)	Vol.	No.
2.310	3980	6
2.320	33702	13
2.330	53509	12
2.340	72939	12
2.350	173887	15

Last trade - 10.12am 13/08/2025 (20 minute delay)


Last $2.33		Change 0.020 ( 1.84 %)
Open	High	Low	Volume
$2.32	$2.33	$2.31	63487
Last updated 10.31am 13/08/2025 ?

MSB (ASX) Chart

MESOBLAST LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories